|Bid||51.36 x 2200|
|Ask||51.60 x 3100|
|Day's Range||50.30 - 51.64|
|52 Week Range||38.82 - 61.71|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||11.62|
|Earnings Date||Jul 28, 2022|
|Forward Dividend & Yield||1.60 (3.19%)|
|Ex-Dividend Date||Jul 28, 2022|
|1y Target Est||58.62|
Subscribe to Yahoo Finance Plus to view Fair Value for PFE
Congressional gridlock on Covid-19 funding might lead to vaccine inequity, but it won’t be a bad thing for the manufacturers, which will charge a higher price in the private market.
Russia’s first default on its foreign debt in more than 100 years is the latest sign that the sanctions levied against the country after the Ukraine invasion have consequences. To be sure, Russia’s default on ruble-denominated bonds in 1998 was a big deal. It forced highly leveraged hedge fund Long Term Capital Management to collapse, a precursor of the financial crisis that struck a decade later.
Pfizer Inc. and BioNTech SE said over the weekend that the change they made to their COVID-19 vaccine that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order a formula change for vaccines in hopes that the modified vaccines could protect against another COVID-19 surge that is expected in the fall and the winter. The seven-day average of new daily COVID-19 cases was 102,818 on Sunday, the t